Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia

Area of Science:

• Hematology
• Molecular Biology
• Genetics

Background:

• Spliceosome mutations are common in myelodysplasia.
• The precise splicing alterations and transcript-level effects remain unclear.

Purpose of the Study:

• To elucidate the landscape of splicing alterations and identify precise targets of spliceosome mutations in myelodysplasia.
• To analyze transcriptomic data from myelodysplasia patients and validate findings using gene editing.

Main Methods:

• Transcriptomic analysis of 265 bone marrow samples.
• CRISPR/Cas9-mediated gene editing for validation.
• Assessment of nonsense-mediated decay susceptibility.

Main Results:

• SF3B1 mutations frequently cause reduced intron-retaining isoforms and 3' splice site alterations, impacting tumor suppressor and metabolic genes.
• SRSF2 and U2AF1 mutations are associated with alternative exon usage, including increased cryptic EZH2 exon inclusion.
• Widespread, small reductions in intron-retaining isoforms are the most common splicing alteration in SF3B1-mutated samples.

Conclusions:

• This study provides a comprehensive landscape of splicing alterations in myelodysplasia.
• Identified precise targets of spliceosome mutations, including tumor suppressors and metabolic genes.
• Findings advance understanding of spliceosome mutation mechanisms in myelodysplasia.